From February 28, 2022 to March 1, 2022, the company has repurchased 53,700 shares, representing 1.58% for ¥69.11 million. With this, the company has completed the repurchase of 53,700 shares, representing 1.58% for ¥69.11 million under the buyback announced on February 28, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,012 JPY | +0.40% | +0.30% | +1.10% |
1st Jan change | Capi. | |
---|---|---|
+1.10% | 21.32M | |
-12.89% | 8.09B | |
+25.86% | 1.22B | |
-8.15% | 354M | |
+6.43% | 280M | |
+8.33% | 225M | |
-47.95% | 80.29M | |
-28.44% | 70.28M | |
+28.50% | 63.87M |
- Stock Market
- Equities
- 9776 Stock
- News Sapporo Clinical Laboratory Inc.
- Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 28, 2022.